Implied Volatility Surging for Ardent Health Stock Options
Investors need to pay close attention to ARDT stock based on the movements in the options market lately.
Zacks Investment Research8/13/2026Neutral
ARDT
Ardent Health Partners, Inc.NYSEHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$1.54B
P/E Ratio
20.17
EPS
$0.54
Beta
0.70
52W High
$15.48
52W Low
$7.71
50-Day MA
$10.16
200-Day MA
$9.71
Dividend Yield
—
Profit Margin
1.22%
Forward P/E
10.39
PEG Ratio
—
About Ardent Health Partners, Inc.
Ardent Health Partners, Inc. is a leading healthcare organization based in Nashville, Tennessee, focused on providing high-quality, patient-driven care through an extensive network of hospitals and outpatient facilities. The company emphasizes innovation and operational excellence, offering a comprehensive range of acute care services tailored to the specific needs of the communities it serves. With a solid financial foundation and a strategic growth plan, Ardent is well-prepared to enhance healthcare access and improve patient outcomes in a dynamic healthcare environment.
Fundamentals
| Revenue (TTM) | $6.41B |
| Gross Profit (TTM) | $3.74B |
| EBITDA | $422.42M |
| Operating Margin | 3.44% |
| Return on Equity | 9.96% |
| Return on Assets | 3.13% |
| Revenue/Share (TTM) | $45.31 |
| Book Value | $9.34 |
| Price-to-Book | 1.14 |
| Price-to-Sales (TTM) | 0.24 |
| EV/Revenue | 0.481 |
| EV/EBITDA | 7.27 |
| Quarterly Earnings Growth (YoY) | -77.10% |
| Quarterly Revenue Growth (YoY) | -1.40% |
| Shares Outstanding | $141.05M |
| Float | $52.09M |
| % Insiders | 23.84% |
| % Institutions | 76.73% |
Historical Volatility
HV 10-Day
37.67%
HV 20-Day
38.62%
HV 30-Day
40.22%
HV 60-Day
55.96%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($12.68 target)
1
Strong Buy6
Buy4
Hold1
Strong SellLatest News
New Strong Sell Stocks for August 7th
ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.
Zacks Investment Research8/7/2026Negative
Ardent Health Q2 Earnings Call Highlights
Ardent Health NYSE: ARDT reported second-quarter revenue of $1.62 billion and adjusted EBITDA of $115 million, as management said cost controls, a favorable payer contract renewal and strong cash flow helped offset weaker-than-expected volumes.
MarketBeat8/5/2026Positive
Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript
Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript
Seeking Alpha8/5/2026Neutral
Ardent Health Reports Second Quarter 2026 Results
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended June 30, 2026. Second Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key oper.
Business Wire8/4/2026Neutral
Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?
Ardent Health, Inc. (ARDT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research7/28/2026Positive
Ardent Health surpasses 1 million patient encounters supported by ambient AI
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced that its physicians and advanced practice providers have surpassed 1 million patient encounters supported by Ambience Healthcare's ambient AI platform, marking a significant milestone in the organization's efforts to reduce clinician burnout, improve the provider experience and strengthen patient care. Ardent-affiliated clinicians using Ambience leverage the technology in 87% of ambulatory encounters across specialtie.
Business Wire7/23/2026Neutral
Kaskela Law Firm Announces Investigation of Ardent Health, Inc. (ARDT) and Encourages Long-Term ARDT Shareholders with Investment Losses to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Ardent Health, Inc. (NYSE: ARDT) (“Ardent”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/ardent/ Recently a securities fraud complaint was filed against Ardent on behalf of certain investors who purchased shares of the company's stock between July 18, 2024 and November 12, 2025 (the “Wrongdoing Period”). According to the com.
Business Wire7/23/2026Neutral
Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its second quarter 2026 results after the market closes on Tuesday, August 4, 2026. A conference call will be held the following day, Wednesday, August 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying pr.
Business Wire7/17/2026Neutral
Do Options Traders Know Something About Ardent Health Stock We Don't?
Investors need to pay close attention to ARDT stock based on the movements in the options market lately.
Zacks Investment Research6/29/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ARDT and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026